Geneos Wealth Management Inc. Sells 3,136 Shares of HCA Healthcare, Inc. $HCA

Geneos Wealth Management Inc. lowered its stake in HCA Healthcare, Inc. (NYSE:HCA) by 78.5% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 861 shares of the company’s stock after selling 3,136 shares during the quarter. Geneos Wealth Management Inc.’s holdings in HCA Healthcare were worth $367,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Ameriflex Group Inc. acquired a new stake in HCA Healthcare in the 2nd quarter valued at approximately $27,000. Chung Wu Investment Group LLC bought a new stake in shares of HCA Healthcare in the second quarter worth $27,000. Clearstead Trust LLC grew its position in HCA Healthcare by 311.8% in the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock valued at $27,000 after purchasing an additional 53 shares in the last quarter. Harbor Capital Advisors Inc. boosted its stake in shares of HCA Healthcare by 82.9% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock worth $32,000 after buying an additional 34 shares during the last quarter. Finally, Twin Peaks Wealth Advisors LLC bought a new position in HCA Healthcare in the second quarter valued at approximately $40,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

HCA has been the subject of a number of research analyst reports. Wells Fargo & Company lifted their price target on HCA Healthcare from $431.00 to $452.00 and gave the stock an “equal weight” rating in a report on Wednesday. Jefferies Financial Group raised their price target on HCA Healthcare from $485.00 to $525.00 and gave the company a “buy” rating in a report on Tuesday, October 28th. Oppenheimer increased their price objective on shares of HCA Healthcare from $400.00 to $500.00 and gave the company an “outperform” rating in a research report on Monday, October 27th. Zacks Research lowered shares of HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 27th. Finally, Mizuho upped their target price on HCA Healthcare from $505.00 to $520.00 and gave the company an “outperform” rating in a research report on Thursday, December 18th. Fourteen equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $485.95.

Insider Buying and Selling at HCA Healthcare

In related news, EVP Michael R. Mcalevey sold 3,892 shares of the firm’s stock in a transaction dated Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the sale, the executive vice president directly owned 3,487 shares of the company’s stock, valued at $1,652,105.73. This trade represents a 52.74% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. 1.30% of the stock is currently owned by corporate insiders.

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $472.40 on Friday. HCA Healthcare, Inc. has a fifty-two week low of $295.00 and a fifty-two week high of $520.00. The business has a fifty day moving average price of $479.87 and a two-hundred day moving average price of $427.38. The stock has a market capitalization of $107.80 billion, a PE ratio of 18.26, a P/E/G ratio of 1.30 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. The firm had revenue of $19.16 billion for the quarter, compared to the consensus estimate of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The business’s revenue for the quarter was up 9.6% on a year-over-year basis. During the same period in the prior year, the company posted $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, equities analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, December 29th. Stockholders of record on Monday, December 15th were paid a $0.72 dividend. The ex-dividend date was Monday, December 15th. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.13%.

Trending Headlines about HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA is among the first health systems to access OpenAI’s new healthcare programs — a move that could drive clinical efficiency, faster workflow automation and potential cost savings if deployed broadly across HCA’s network. HCA Healthcare among first to access OpenAI’s new health care programs
• Positive Sentiment: OpenAI launched ChatGPT for Healthcare at several large systems — broader industry adoption reduces implementation risk and can accelerate HCA’s rollout benefits (clinical decision support, patient triage, revenue-cycle automation). OpenAI launches ChatGPT for Healthcare at several large health systems
• Positive Sentiment: HCA and AdventHealth are expanding ER footprints in Florida — inorganic/greenfield capacity additions should help volume growth and market share in a high-margin service line. HCA, AdventHealth expand Florida ER footprints
• Positive Sentiment: A new emergency facility opened in Arlington — incremental capacity and local access that can lift admissions and outpatient revenues. New emergency health facility opens in Arlington
• Positive Sentiment: HCA Florida Capital Hospital and UCF launched a medical residency program — strengthens physician pipeline and could reduce staffing pressures/costs over time. HCA Florida Capital Hospital, UCF create new medical residency program
• Positive Sentiment: An analyst raised HCA’s price target to $520 — a bullish signal that supports upside in the medium term if execution and margins track. HCA Healthcare (NYSE:HCA) Price Target Raised to $520.00
• Neutral Sentiment: HCA Georgia hospital named a new CFO — routine executive hire that supports local operations but is not material company‑wide. HCA Georgia hospital taps CFO
• Neutral Sentiment: HCA rolled out a “Talk to a nurse for free” service — positive PR and access initiative but limited immediate financial impact. HCA says: ‘Talk to a nurse for free’
• Negative Sentiment: CEO exit after nine months at an HCA Virginia behavioral health hospital — leadership turnover can signal integration or operational issues in a growing behavioral-health segment. HCA Virginia behavioral health hospital CEO exits after 9 months
• Negative Sentiment: A MarketWatch note flagged HCA’s relative underperformance versus peers on a recent trading day — highlights near‑term downside risk if investors rotate into other healthcare names. HCA Healthcare Inc. stock underperforms Thursday when compared to competitors despite daily gains

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.